COMMUNIQUÉS West-GlobeNewswire

-
Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting
02/04/2025 -
Investigators to Present Clinical Trial Results Showing Neflamapimod Slows Clinical Progression in Dementia with Lewy Bodies in Oral Presentation at AD/PD™ 2025
02/04/2025 -
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
02/04/2025 -
The Ensign Group Adds Two Operations in California
02/04/2025 -
Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California
02/04/2025 -
Former EPA Flint Emergency Coordinator Expands Groundbreaking Drinking Water Training Program
02/04/2025 -
The Ensign Group Purchases Two Facilities in Washington
02/04/2025 -
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
02/04/2025 -
The Ensign Group Expands in California
02/04/2025 -
Helsinn Group submits a new formulation of AKYNZEO® to the European Medicines Agency (EMA)
02/04/2025 -
AVEROA Receives Positive Opinion from the European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD)
02/04/2025 -
Boehringer Ingelheim reaches more patients in 2024 and prepares new medicine launches
02/04/2025 -
ENA Respiratory Announces Publication Supporting the Potential of its Novel Intranasal Therapy INNA-051 to Reduce the Impact of Viral Respiratory Infections in Older Adults
02/04/2025 -
CMR Surgical secures more than $200M to accelerate growth
02/04/2025 -
Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay
02/04/2025 -
Zelluna ASA [ZLNA]: Annual Report 2024
02/04/2025 -
IBA signs contract for a Proteus®ONE solution to be installed at the Tri-Service General Hospital in Taiwan
02/04/2025 -
IBA signe un contrat pour installer une solution Proteus®ONE au Tri-Service General Hospital à Taïwan
02/04/2025 -
Curium Announces Approval of Generic DTPA - Kit for the Preparation of Technetium Tc 99m Pentetate Injection in the U.S.
02/04/2025
Pages